申请人:Toyama Chemical Co., Ltd.
公开号:US04436921A1
公开(公告)日:1984-03-13
A 1-(4-aminobenzyl)-2,3-dioxopiperazine derivative represented by the formula: ##STR1## and an acid addition salt thereof have excellent carcinostatic activity but a low toxicity. Therefore, said compounds are useful as medicines and also as intermediates.
一种由以下公式表示的1-(4-氨基苄基)-2,3-二氧代哌嗪衍生物:##STR1##及其酸盐加合物具有出色的抗癌活性,但毒性较低。因此,这些化合物可用作药物,也可用作中间体。